Document:

exv10w17

	 	 	 	 	 

WRIGHT MEDICAL GROUP, INC.

Restricted Stock Grant Agreement

Executive

Award Granted to (“Grantee”):

Grant Date:

Number of Shares (“Shares”):

     THIS RESTRICTED STOCK GRANT AGREEMENT (the “Agreement”) is made as of the Grant Date by and
between Wright Medical Group, Inc., a Delaware corporation with its principal place of business at
5677 Airline Road, Arlington, Tennessee 38002 (the “Company”) and Grantee pursuant to the Wright
Medical Group, Inc. 1999 Equity Incentive Plan, as amended from time to time (the “Plan”) and which
is hereby incorporated by reference.

     WHEREAS, Grantee is associated with the Company or its affiliate as an employee; and

     WHEREAS, the Compensation Committee of the Company’s Board of Directors (the “Committee”) has
authorized that Grantee be granted shares of the Company’s Common Stock (“Stock”) subject to the
restrictions stated below;

     NOW, THEREFORE, the parties agree as follows:

	1.	 	Grant of Stock. Subject to the terms and conditions of this Agreement and of the Plan, the
Company hereby grants to Grantee the Shares.
	 
	2.	 	Vesting Schedule. The interest of Grantee in the Shares shall vest as to one-fourth (1/4) of
the Shares on the first anniversary of the Grant Date, and as to an additional one-fourth (1/4)
on each succeeding anniversary date, so as to be 100% vested on the fourth anniversary
thereof, conditioned upon Grantee’s continued association with the Company as of each vesting
date. Notwithstanding the foregoing, the interest of Grantee in the Shares shall vest as to:

	 	2.1.	 	100% of the then unvested Shares upon a Change of Control. For purposes of this
Agreement, a “Change of Control” shall mean the first to occur on or after the Grant Date
of any of the following:

(a) The acquisition by any individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule
13d-3 promulgated under the Exchange Act) of 50% or more (on a fully diluted basis) of
either (A) the then outstanding shares of Stock, taking into account as outstanding for
this purpose such Stock issuable upon the exercise of options or warrants, the
conversion of convertible stock or debt, and the exercise of any similar right to
acquire such Stock (the “Outstanding Company Common Stock”) or (B) the combined voting
power of the then outstanding voting securities of the Company entitled to vote
generally in the election of directors (the “Outstanding Company Voting Securities”);
provided, however, that for purposes of this subsection (a), the following acquisitions
shall not constitute a Change of Control: (x) any acquisition by the Company or any
“affiliate” of the Company, within the meaning of 17 C.F.R. § 230.405 (an “Affiliate”),
(y) any acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any Affiliate, (z) any acquisition by any corporation or
business entity pursuant to a transaction which complies with clauses (A) and (B) of
subsection (a) of this Section 2.1 (persons and entities described in clauses (x), (y),
and (z) being referred to herein as “Permitted Holders”);

(b) The consummation of a reorganization, merger or consolidation or sale or other disposition of
all or substantially all of the assets of the Company (a “Business Combination”),

 

 

Restricted Stock Grant Agreement

Page 2

in each case, unless, following such Business Combination, (A) all or substantially all
of the individuals and entities who were the beneficial owners, respectively, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities immediately
prior to such Business Combination beneficially own, directly or indirectly, more than
60% of, respectively, the then outstanding shares of common stock and the combined
voting power of the then outstanding voting securities entitled to vote generally in the
election of directors, as the case may be, of the corporation resulting from such
Business Combination (including, without limitation, a corporation which as a result of
such transaction owns the Company or all or substantially all of the Company’s assets
either directly or through one or more subsidiaries) in substantially the same
proportions as their ownership, immediately prior to such Business Combination, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case
may be, (B) no Person (excluding any Permitted Holder) beneficially owns, directly or
indirectly, 50% or more (on a fully diluted basis) of, respectively, the then
outstanding shares of common stock of the corporation resulting from such Business
Combination, taking
into account as outstanding for this purpose such common stock issuable upon the
exercise of options or warrants, the conversion of convertible stock or debt, and the
exercise of any similar right to acquire such common stock, or the combined voting power
of the then outstanding voting securities of such corporation except to the extent that
such ownership existed prior to the Business Combination, and (C) at least a majority of
the members of the board of directors of the corporation resulting from such Business
Combination were members of the incumbent Board at the time of the execution of the
initial agreement providing for such Business Combination;

(c) The approval by the stockholders of the Company of a complete liquidation or
dissolution of the Company;

(d) The sale of at least 80% of the assets of the Company to an unrelated party, or
completion of a transaction having a similar effect; or

(e) The individuals who on the date of this Agreement constitute the Board of Directors
thereafter cease to constitute at least a majority thereof; provided that any person
becoming a member of the Board of Directors subsequent to the date of this Agreement and
whose election or nomination was approved by a vote of at least two-thirds of the
directors who then comprised the Board of Directors immediately prior to such vote shall
be considered a member of the Board of Directors on the date of this Agreement.

	 	2.2.	 	100% of the unvested Shares upon Grantee’s death.

	3.	 	Restrictions.

	 	3.1.	 	The Shares granted hereunder may not be sold, pledged or otherwise transferred until
the Shares become vested in accordance with this Agreement. The period of time between the
Grant Date and the date that the Shares become vested is referred to as the “Restriction
Period.”
	 
	 	3.2.	 	If Grantee’s association with the Company is terminated, the balance of the Shares
subject to the provisions of this Agreement which have not vested at the time of Grantee’s
termination shall be forfeited by Grantee, and ownership transferred back to the Company.
	 
	 	3.3.	 	By accepting the Shares, Grantee represents and agrees for Grantee and Grantee’s
transferees (whether by will or the laws of descent and distribution) that:

 

 

Restricted Stock Grant Agreement

Page 3

(a) For the period commencing on the Grant Date and ending on the first anniversary
of the termination of Grantee’s employment (such period is hereinafter referred to as
the “Covenant Period”), with respect to any State in which the Company is engaged in
business during Grantee’s employment with the Company, Grantee shall not participate or
engage, directly or indirectly, for Grantee or on behalf of or in conjunction with any
person, partnership, corporation or other entity, whether as an employee, agent,
officer, director, stockholder, partner, joint venturer, investor or otherwise, in any
business activities if such activity consists of any activity undertaken or expressly
planned to be undertaken by the Company or any of its subsidiaries or by Grantee at any
time during Grantee’s employment.

(b) Except with the Company’s prior written approval or as may otherwise be required by
law or legal process, Grantee shall not disclose any material or information which is
confidential to the Company or its subsidiaries and not in the public domain or
generally known in the industry, whether tangible or intangible, made available,
disclosed or otherwise known to Grantee as a result of Grantee’s employment with the
Company.

(c) During the Covenant Period, Grantee shall not attempt to influence, persuade or
induce, or assist any other person in so persuading or inducing, any employee of the
Company or its subsidiaries to give up, or to not commence, employment or a business
relationship with the Company.

	 	3.4.	 	The Company shall have the right, but not the obligation, to purchase and acquire from
Grantee any or all of the Shares (the “Repurchased Shares”) if the Committee reasonably
determines that Grantee has violated the covenants set forth in this Agreement or Grantee’s
employment is terminated or could have been terminated for Cause (as defined in the Plan).
The Company may exercise the right granted to it under this Section 3.4 by delivering
written notice to Grantee stating that the Company is exercising the repurchase right
granted to it under this Section 3.4. The delivery of such notice by the Company to
Grantee shall constitute a binding commitment of the Company to purchase and acquire all of
the Repurchased Shares. The total purchase price for the Repurchased Shares shall be
delivered to the Grantee against delivery by Grantee of certificates evidencing the
Repurchased Shares no later than 30 days after the delivery of the election notice by the
Company. The price per share of the Repurchased Shares shall be the lesser of 1) the Fair
Market Value (as defined in the Plan) of each of the Repurchased Shares on the date of the
Company’s delivery of its written notice to Grantee or 2) the Fair Market Value of each of
the Repurchased Shares on the date that such shares vested to the Grantee without regard to
any election by the Grantee under Section 83(b) of the Internal Revenue Code of 1986, as
amended (the “Code”).
	 
	 	3.5.	 	The Company shall have the right, and not the obligation, to cancel any or all of the
Shares if the Committee reasonably determines that Grantee has violated the covenants set
forth in this Agreement. The Company may exercise the right granted to it under this
Section 3.5 by delivering a written notice to Grantee stating that the Company is
exercising the cancellation right granted to it under this Section 3.5.
	 
	 	3.6.	 	Notwithstanding anything in this Section 3 to the contrary, the Company shall not be
obligated to purchase any Stock at any time to the extent that the purchase would result in
a violation of any law, statute, rule, regulation, order, writ, injunction, decree or
judgment promulgated or entered by any Federal, state, local or foreign court or
governmental authority applicable to the Company or any of its property.
	 
	 	3.7.	 	The parties intend the restrictions in Section 3.3 to be completely severable and independent, and
any invalidity or unenforceability of any one or more such restrictions shall not render

 

 

Restricted Stock Grant Agreement

Page 4

	 	 	 	invalid or unenforceable any one or more restrictions.

	4.	 	Legend. All certificates representing any shares of Stock subject to the provisions of this
Agreement shall have endorsed thereon the following legend:

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A
RESTRICTED STOCK GRANT AGREEMENT BETWEEN THE COMPANY AND THE
REGISTERED HOLDER, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL
OFFICE OF THIS COMPANY.

	5.	 	Escrow. The certificate or certificates evidencing the Shares subject hereto shall be
delivered to and deposited with the Secretary of the Company as Escrow Agent in this
transaction. The Shares may also be held in a restricted book entry account in the name of
Grantee. Such certificates or such book entry shares are to be held by the Escrow Agent until
termination of the Restriction Period, when they shall be released by the Escrow Agent to
Grantee.
	 
	6.	 	Stockholder Rights. During the Restriction Period, Grantee shall have all the rights of a
stockholder with respect to the Shares except for the right to transfer the Shares as set
forth in Section 3 and except as set forth in Section 7. Accordingly, Grantee shall have the
right to vote the Shares and to receive any cash dividends paid to or made with respect to the
Shares.
	 
	7.	 	Changes in Stock. In the event that as a result of (i) any stock dividend, stock split or
other change in the Stock, or (ii) any merger or sale of all or substantially all of the
assets or other acquisition of the Company, and by virtue of any such change Grantee shall in
Grantee’s capacity as owner of unvested shares of Stock which have been awarded to Grantee
(the “Prior Stock”) be entitled to new or additional or different shares or securities, such
new or additional or different shares or securities shall thereupon be considered unvested
Shares and shall be subject to all of the conditions and restrictions which were applicable to
the Prior Stock pursuant to this Agreement.
	 
	8.	 	Permanent and Total Disability of Grantee. In the event of the permanent and total
disability of Grantee, any unpaid but vested Shares shall be paid to Grantee if legally
competent or to a legally designated guardian or representative if Grantee is legally
incompetent.
	 
	9.	 	Death of Grantee. In the event of Grantee’s death after the vesting date but prior to the
payment of Shares, such Shares shall be paid to Grantee’s estate or designated beneficiary.
	 
	10.	 	Taxes. Grantee understands that Grantee will recognize income for federal and, if
applicable, state income tax purposes in an amount equal to the amount by which the fair
market value of the Shares, as of the Grant Date or vesting date, as applicable, exceeds any
consideration paid by Grantee for such Shares. Grantee shall be liable for any and all taxes,
including withholding taxes, arising out of this grant or the vesting of Shares hereunder. By
accepting the Shares, Grantee covenants to report such income in accordance with applicable
federal and state laws. To the extent that the receipt of the Shares or the end of the
Restriction Period results in income to Grantee and withholding obligations of the Company,
including federal or state withholding obligations, Grantee agrees that the obligation shall
be satisfied in the manner Grantee has chosen by checking one of the following boxes:

	 	o	 	At least one working day prior to the vesting date Grantee may deliver to the Company an amount of
cash determined by the Company to be adequate to satisfy the Company’s withholding obligation. If
Grantee does not deliver such amount of cash, the Company shall withhold an amount of the Grantee’s
current or future remuneration in an amount that satisfies the Company’s withholding obligation.
Notwithstanding the foregoing, the Company may in its sole discretion withhold from the Shares to
be issued the specific number of

 

 

Restricted Stock Grant Agreement

Page 5

	 	 	 	Shares having a fair market value on the vesting date equal to the amount required to
satisfy the Company’s withholding obligation.
	 
	 	o	 	The Company shall retain and instruct a registered broker(s) to sell such number of
Shares necessary to satisfy the Company’s withholding obligations, after deduction of the
broker’s commission, and the broker shall remit to the Company the cash necessary in order
for the Company to satisfy its withholding obligations. Grantee covenants to execute any
such documents as are requested by the broker of the Company in order to effectuate the
sale of the Shares and payment of the tax obligations to the Company. The Grantee
represents to the Company that, as of the date hereof, he or she is not aware of any
material nonpublic information about the Company or the Shares. The Grantee and the
Company have structured this Agreement to constitute a “binding contract” relating to the
sale of Shares pursuant to
this Section, consistent with the affirmative defense to liability under Section 10(b)
of the Exchange Act under Rule 10b5-1(c) promulgated under the Exchange Act.*

	11.	 	Miscellaneous.

	 	11.1.	 	The Company shall not be required (i) to transfer on its books any shares of Stock of
the Company which have been sold or transferred in violation of any provisions set forth in
this Agreement, or (ii) to treat as owner of such shares or to accord the right to vote as
such owner or to pay dividends to any transferee to whom such shares shall have been so
transferred.
	 
	 	11.2.	 	The parties agree to execute such further instruments and to take such action as may
be reasonably necessary to carry out the intent of this Agreement.
	 
	 	11.3.	 	Any notice required or permitted hereunder shall be given in writing and shall be
deemed effectively given upon delivery to Grantee at the address of Grantee then on file
with the Company.
	 
	 	11.4.	 	Neither the Plan nor this Agreement nor any provisions under either shall be construed
so as to grant Grantee any right to remain associated with the Company or any of its
affiliates.
	 
	 	11.5.	 	This Agreement constitutes the entire agreement of the parties with respect to the
subject matter hereof.

 

			
	*	 	By selecting the second option, Grantee understands
that the sale of Shares to satisfy the Company’s withholding obligations will
be considered a sale for purposes of short-swing liability under Section 16(b)
of the Exchange Act. Any profit realized in a purchase of shares of the
Company’s stock within six months of the sale may be recovered by the Company
or by a stockholder of the Company on behalf of the Company.

 

 

Restricted Stock Grant Agreement

Page 6

     This Agreement and the Shares evidenced by this Agreement will not be effective until an
original signed Agreement is received by the Wright Medical Group, Inc. Legal Department. Please
print and sign this Agreement immediately, then send the signed Agreement to the Wright Medical
Group, Inc. Legal Department as soon as possible.

AGREED AND ACCEPTED:

	 	 	 	 	 	 	 
	GRANTEE:	 	WRIGHT MEDICAL GROUP, INC.	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Jason P. Hood, Vice President,

General Counsel, and Secretaryexv10w18

Exhibit 10.18

WRIGHT MEDICAL GROUP, INC.

Phantom Stock Unit Grant Agreement

(Non-US Grantees)

Award Granted to (“Grantee”):

Grant Date:

Number of Units (“Units”):

     THIS PHANTOM STOCK UNIT GRANT AGREEMENT (the “Agreement”) including any country-specific
appendix hereto, is made as of the Grant Date by and between Wright Medical Group, Inc., a Delaware
corporation with its principal place of business at 5677 Airline Road, Arlington, Tennessee 38002
(the “Company”) and Grantee pursuant to the Wright Medical Group, Inc. 1999 Equity Incentive Plan,
as amended from time to time (the “Plan”) and which is hereby incorporated by reference.

     WHEREAS, Grantee is associated with the Company or its affiliate as an employee; and

     WHEREAS, the Compensation Committee of the Company’s Board of Directors (the “Committee”) has
authorized that Grantee be granted Phantom Stock Units (“Units”) that upon vesting will be
converted to shares of the Company’s Common Stock (“Stock”) subject to the restrictions stated
below;

     NOW, THEREFORE, the parties agree as follows:

	1.	 	Grant of Units. Subject to the terms and conditions of this Agreement and the Plan, the
Company hereby grants Units to Grantee.
	 
	2.	 	Vesting Schedule. The Units shall vest as to one-fourth (1/4) of the Units on the first
anniversary of the Grant Date, and as to an additional one-fourth (1/4) on each succeeding
anniversary thereof. Provided, however, that Grantee’s ability to vest in any Units is
specifically conditioned upon Grantee’s continued active service in any capacity for the
Company or any controlled group member of the Company (within the contemplation of U.S.
Internal Revenue Code section 414(b) or (c)) until the vesting event. Notwithstanding the
foregoing conditional annual vesting schedule, the interest of Grantee in the Units shall vest
as to:

	 	2.1.	 	100% of the then unvested Units upon a Change of Control. For purposes of this
Agreement, a “Change of Control” shall mean the first to occur on or after the Grant Date
of any of the following:

(a) The acquisition by any individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the U.S. Securities Exchange Act of 1934, as amended (the
“Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3
promulgated under the Exchange Act) of 50% or more (on a fully diluted basis) of either
(A) the then outstanding shares of Stock, taking into account as outstanding for this
purpose such Stock issuable upon the exercise of options or warrants, the conversion of
convertible stock or debt, and the exercise of any similar right to acquire such Stock
(the “Outstanding Company Common Stock”) or (B) the combined voting power of the then
outstanding voting securities of the Company entitled to vote generally in the election
of directors (the “Outstanding Company Voting Securities”); provided, however, that for
purposes of this subsection (a), the following acquisitions shall not constitute a
Change of Control: (x) any acquisition by the Company or any “affiliate” of the
Company, within the meaning of 17 U.S. C.F.R. § 230.405 (an “Affiliate”), (y) any
acquisition by any employee benefit plan (or related trust) sponsored or maintained by
the Company or any Affiliate, (z) any acquisition by any corporation or business entity
pursuant to a transaction which complies with clauses (A) and (B) of subsection (a) of
this Section 2.1 (persons and entities described in clauses (x), (y), and (z) being
referred to herein as “Permitted Holders”);

 

 

Phantom Stock Unit Grant Agreement

Page 2

(b) The consummation of a reorganization, merger or consolidation or sale or other
disposition of all or substantially all of the assets of the Company (a “Business
Combination”), in each case, unless, following such Business Combination, (A) all or
substantially all of the individuals and entities who were the beneficial owners,
respectively, of the Outstanding Company Common Stock and Outstanding Company Voting
Securities immediately prior to such Business Combination beneficially own, directly or
indirectly, more than 60% of, respectively, the then outstanding shares of common stock
and the combined voting power of the then outstanding voting securities entitled to vote
generally in the election of directors, as the case may be, of the corporation resulting
from such Business Combination (including, without limitation, a corporation which as a
result of such transaction owns the Company or all or substantially all of the Company’s
assets either directly or through one or more subsidiaries) in substantially the same
proportions as their ownership, immediately prior to such Business Combination, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case
may be, (B) no Person (excluding any Permitted Holder) beneficially owns, directly or
indirectly, 50% or more (on a fully diluted basis) of, respectively, the then
outstanding shares of common stock of the corporation resulting from such Business
Combination, taking into account as outstanding for this purpose such common stock
issuable upon the exercise of options or warrants, the conversion of convertible stock
or debt, and the exercise of any similar right to acquire such common stock, or the
combined voting power of the then outstanding voting securities of such corporation
except to the extent that such ownership existed prior to the Business Combination, and
(C) at least a majority of the members of the board of directors of the corporation
resulting from such Business Combination were members of the incumbent Board at the time
of the execution of the initial agreement providing for such Business Combination;

(c) The approval by the stockholders of the Company of a complete liquidation or
dissolution of the Company;

(d) The sale of at least 80% of the assets of the Company to an unrelated party, or
completion of a transaction having a similar effect; or

(e) The individuals who on the date of this Agreement constitute the Company’s Board of
Directors thereafter cease to constitute at least a majority thereof; provided that any
person becoming a member of the Board of Directors subsequent to the date of this
Agreement and whose election or nomination was approved by a vote of at least two-thirds
of the directors who then comprised the Board of Directors immediately prior to such
vote shall be considered a member of the Board of Directors on the date of this
Agreement.

	 	2.2.	 	100% of the unvested Units upon Grantee’s death.

	3.	 	Conversion into Stock.

	 	3.1	 	Subject to Sections 3.6 and 4 below, shares of Stock will be issued and become free of
restrictions as soon as practicable following vesting of the Units, provided that Grantee
has satisfied all Tax-Related Items as defined in Section 5 of this Agreement and Grantee
has completed, signed and returned any documents and taken any additional action that the
Company deems appropriate to enable it to accomplish the delivery of the shares of Stock.
In no event shall the Company issue the shares of Stock later than March 15 of the calendar
year which begins after the calendar year in which the vesting event occurs, unless Grantee
fails to satisfy the foregoing conditions for delivery not fewer than seven (7) days before
such date, in which event all such shares of Stock shall be forfeited.
	 
	 	3.2	 	The shares of Stock will be issued (i) in the event of Grantee’s death, in the name of
Grantee’s estate, (ii) a legally designated guardian or representative if Grantee is
legally incompetent, or

 

 

Phantom Stock Unit Grant Agreement

Page 3

	 	 	 	(iii) otherwise, to Grantee, and may be effected by recording shares on the stock records
of the Company or by crediting shares in an account established on Grantee’s behalf with a
brokerage firm or other custodian, in each case determined by the Company in its
discretion.
	 
	 	3.3	 	Each Unit will be converted into one (1) share of Stock.
	 
	 	3.4	 	In no event shall the Company be obligated to issue fractional shares.
	 
	 	3.5	 	In no event shall the Company settle the conversion of Units with cash, nor shall any
dividend equivalents or interest thereon be credited with respect to the Units.
	 
	 	3.6	 	Not withstanding the foregoing,

(a) the Company shall not be obligated to deliver any shares of Stock during any period
the Company determines that the conversion of a Unit or the delivery of shares hereunder
would violate any laws of the United States or Grantee’s country of residence or employment
and/or may issue shares subject to any restrictive legends that, as determined by the
Company’s counsel, is necessary to comply with securities or other regulatory requirements,
and

(b) the date on which the shares are issued may include a delay in order to provide the
Company such time as it determines appropriate to address Tax-Related Items and other
administrative matters.

	 	3.7	 	Grantee will have rights of a stockholder of Stock only after the shares of Stock have
been issued to Grantee following vesting of his Units and satisfaction of all other
conditions to the issuance of those shares as set forth in the Agreement. Units shall not
entitle Grantee to any rights of a stockholder of Stock and there are no voting or dividend
rights with respect to the Units. Units shall remain terminable pursuant to this Agreement
at all times until they vest and convert to shares of Stock. Notwithstanding the
foregoing, in the event of a stock dividend, stock split, or other change in the Stock, the
number of shares of Stock that each unvested Unit is convertible into shall be
proportionately increased or decreased, as the case may be.

	4.	 	Restrictions.

	 	4.1.	 	The Units granted hereunder may not be sold, pledged or otherwise transferred in any
way whether by operation of law or otherwise, and may not be subject to execution,
attachment or similar process. Any attempt to sell, pledge or otherwise transfer the Units
other than as permitted above, shall be void and unenforceable.
	 
	 	4.2.	 	Units that have not yet vested at the time Grantee ceases providing substantial active
services in any capacity for the Company or any such controlled group member, as described
in U.S. Internal Revenue Code Section 414(b) or (c), shall be forfeited by Grantee.
	 
	 	4.3.	 	By accepting the Units, Grantee represents and agrees for himself and his transferees
(whether by will or the laws of descent and distribution) that:

(a) For the period commencing on the Grant Date and ending on the first anniversary of
the termination of Grantee’s active employment (such period is hereinafter referred to
as the “Covenant Period”), with respect to any Country in which the Company is engaged
in business during Grantee’s employment with the Company, Grantee shall not participate
or engage, directly or indirectly, for himself or on behalf of or in conjunction with
any person, partnership, corporation or other entity, whether as an employee, agent,
officer, director, stockholder, partner, joint venturer, investor or otherwise, in any
business activities if such activity consists of any activity undertaken or expressly
planned to be undertaken by the Company or any of its subsidiaries or by Grantee at any
time during Grantee’s employment.

 

 

Phantom Stock Unit Grant Agreement

Page 4

(b) Except with the Company’s prior written approval or as may otherwise be required by
law or legal process, Grantee shall not disclose any material or information which is
confidential to the Company or its subsidiaries and not in the public domain or
generally known in the industry, whether tangible or intangible, made available,
disclosed or otherwise known to Grantee as a result of his employment with the Company.

(c) During the Covenant Period, Grantee shall not attempt to influence, persuade or
induce, or assist any other person in so persuading or inducing, any employee of the
Company or its subsidiaries to give up, or to not commence, employment or a business
relationship with the Company.

	 	4.4.	 	The Company shall have the right, but not the obligation, to purchase and acquire from
Grantee any or all of the Stock (the “Repurchased Stock”) received pursuant to any vested
Units if the Committee reasonably determines that Grantee has violated the covenants set
forth in this Agreement or Grantee’s active employment is terminated or could have been
terminated for Cause (as defined in the Plan). The Company may exercise the right granted
to it under this Section 4.4 by delivering written notice to Grantee stating that the
Company is exercising the repurchase right granted to it under this Section 4.4. The
delivery of such notice by the Company to Grantee shall constitute a binding commitment of
the Company to purchase and acquire all of the Repurchased Stock. The total purchase price
for the Repurchased Stock shall be delivered to the Grantee against delivery by Grantee of
certificates evidencing the Repurchased Stock no later than 30 days after the delivery of
the election notice by the Company. The price per share of the Repurchased Stock shall be
the lesser of (1) the Fair Market Value (as defined in the Plan) of the Repurchased Stock
on the date of the Company’s delivery of its written notice to Grantee or (2) the Fair
Market Value of the Repurchased Stock on the date that the Units related to the Repurchased
Stock vested to the Grantee.
	 
	 	4.5.	 	The Company shall have the right, but not the obligation, to cancel any or all of the
unvested Units if the Committee reasonably determines that Grantee has violated the
covenants set forth in this Agreement. The Company may exercise the right granted to it
under this Section 4.5 by delivering a written notice to Grantee stating that the Company
is exercising the cancellation right granted to it under this Section 4.5.
	 
	 	4.6.	 	The parties intend the restrictions in Section 4.3, 4.4 or 4.5 to be completely
severable and independent, and any invalidity or unenforceability of any one or more such
restrictions shall not render invalid or unenforceable any one or more restrictions.

	5.	 	Responsibility for Taxes. Regardless of any action the Company or Grantee’s employer (the
“Employer”) takes with respect to any or all income tax, social insurance, payroll tax,
payment on account or other tax-related items related to Grantee’s participation in the Plan
and legally applicable to Grantee or deemed by the Company or the Employer to be an
appropriate charge to Grantee even if technically due by the Company or the Employer
(“Tax-Related Items”), Grantee acknowledges that the ultimate liability for all Tax-Related
Items is and remains Grantee’s responsibility and may exceed the amount actually withheld by
the Company or the Employer. Grantee further acknowledges that the Company and/or the
Employer (1) make no representations or undertakings regarding the treatment of any
Tax-Related Items in connection with any aspect of the Units, including, but not limited to,
the grant, vesting or conversion of the Units, the issuance of shares of Stock upon conversion
of the Units, the subsequent sale of shares of Stock issued or to be issued upon conversion of
the Units and the receipt of any dividends; and (2) do not commit to and are under no
obligation to structure the terms of the grant or any aspect of the Units to reduce or
eliminate Grantee’s liability for Tax-Related Items or achieve any particular tax result.
Further, if Grantee has become subject to tax in more than one jurisdiction between the Grant
Date and the date of any relevant taxable event, Grantee acknowledges that the Company and/or
the Employer (or former

 

 

Phantom Stock Unit Grant Agreement

Page 5

	 	 	employer, as applicable) may be required to withhold or account for Tax-Related Items in more
than one jurisdiction.

	 	 	Prior to any relevant taxable or tax withholding event, as applicable, Grantee will pay or make
adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related
Items. In this regard, Grantee authorizes the Company and/or the Employer, or their respective
agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by
one or a combination of the following:

(a) withholding from Grantee’s wages or other cash compensation paid to Grantee by the
Company and/or the Employer; or

(b) selling and withholding from proceeds of the sale such number of shares of Stock to
be issued to Grantee upon conversion of the Units necessary to satisfy the obligations
with regard to all Tax-Related Items and any broker’s commission related to the sale,
either through a voluntary sale or through a mandatory sale arranged by the Company (on
Grantee’s behalf pursuant to this authorization); or

(c) withholding of shares of Stock to be issued to Grantee upon conversion of the Units.

To avoid negative accounting treatment, the Company may withhold or account for Tax-Related
Items by considering applicable minimum statutory withholding amounts or other applicable
withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in
shares of Stock, for tax purposes, Grantee is deemed to have been issued the full number of
shares of Stock subject to the vested Units, notwithstanding that a number of the shares of
Stock are held back solely for the purpose of paying the Tax-Related Items due as a result of
any aspect of Grantee’s participation in the Plan.

Grantee shall pay to the Company or the Employer any amount of Tax-Related Items that the
Company or the Employer may be required to withhold or account for as a result of Grantee’s
participation in the Plan that cannot be satisfied by the means previously described. The
Company may refuse to issue or deliver the shares of Stock or the proceeds of the sale of shares
of Stock, if Grantee fails to comply with his or her obligations in connection with the
Tax-Related Items.

Finally, Grantee represents to the Company that, as of the date hereof, he or she is not aware
of any material nonpublic information about the Company or the shares of Stock. Grantee and the
Company have structured this Agreement to constitute a “binding contract” relating to the sale
of shares of Stock pursuant to this Section, consistent with the affirmative defense to
liability under Section 10(b) of the Exchange Act of 1934 under Rule 10b5-1(c) promulgated under
the Exchange Act.

	6.	 	Nature of Grant. In accepting the grant, Grantee acknowledges that:

(a) the Plan is established voluntarily by the Company, it is discretionary in nature
and it may be modified, amended, suspended or terminated by the Company at any time;

(b) the grant of the Units is voluntary and occasional and does not create any
contractual or other right to receive future grants of Units, or benefits in lieu of
Units, even if Units have been granted repeatedly in the past;

(c) all decisions with respect to future grants of Units, if any, will be at the sole
discretion of the Company;

 

 

Phantom Stock Unit Grant Agreement

Page 6

(d) Grantee’s participation in the Plan shall not create a right to further employment
with the Employer and shall not interfere with the ability of the Employer to terminate
Grantee’s employment relationship at any time;

(e) Grantee is voluntarily participating in the Plan;

(f) the Units and the shares of Stock subject to the Units are an extraordinary item
that does not constitute compensation of any kind for services of any kind rendered to
the Company or the Employer, and which is outside the scope of Grantee’s employment
contract, if any;

(g) the Units and the shares of Stock subject to the Units are not intended to replace
any pension rights or compensation;

(h) the Units and the shares of Stock subject to the Units are not part of normal or
expected compensation or salary for any purposes, including, but not limited to,
calculating any severance, resignation, termination, redundancy, dismissal, end of
service payments, bonuses, long-service awards, pension or retirement or welfare
benefits or similar payments and in no event should be considered as compensation for,
or relating in any way to, past services for the Company, the Employer or any subsidiary
or affiliate of the Company;

(i) the grant of Units and Grantee’s participation in the Plan will not be interpreted
to form an employment contract or relationship with the Company or any subsidiary or
affiliate of the Company;

(j) the future value of the underlying shares of Stock is unknown and cannot be
predicted with certainty;

(k) in consideration of the grant of the Units, no claim or entitlement to compensation
or damages shall arise from forfeiture of the Units resulting from termination of
Grantee’s employment with the Company or the Employer (for any reason whatsoever and
whether or not in breach of local labor laws) or a violation of the covenants and
Grantee irrevocably releases the Company and the Employer from any such claim that may
arise; if, notwithstanding the foregoing, any such claim is found by a court of
competent jurisdiction to have arisen, Grantee shall be deemed irrevocably to have
waived his or her entitlement to pursue such claim;

(l) in the event of termination of Grantee’s employment (whether or not in breach of
local labor laws), Grantee’s right to vest in the Units under the Plan, if any, will
terminate effective as of the date that Grantee is no longer actively employed and will
not be extended by any notice period mandated under local law (e.g., active employment
would not include a period of “garden leave” or similar period pursuant to local law);
the Committee shall have the exclusive discretion to determine when Grantee is no longer
actively employed for purposes of the Units; and

(m) the Units and the benefits under the Plan, if any, will not automatically transfer
to another company in the case of a merger, take-over or transfer of liability.

	7.	 	No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice,
nor is the Company making any recommendations regarding Grantee’s participation in the Plan,
or Grantee’s acquisition or sale of the underlying shares of Stock. Grantee is hereby advised
to consult

 

 

Phantom Stock Unit Grant Agreement

Page 7

	 	 	with his or her own personal tax, legal and financial advisors regarding Grantee’s participation
in the Plan before taking any action related to the Plan.
	 
	8.	 	Data Privacy. Grantee hereby explicitly and unambiguously consents to the collection, use
and transfer, in electronic or other form, of Grantee’s personal data as described in this
Agreement and any other Unit grant materials by and among, as applicable, the Employer, the
Company and its subsidiaries and affiliates for the exclusive purpose of implementing,
administering and managing Grantee’s participation in the Plan.
	 
	 	 	Grantee understands that the Company and the Employer may hold certain personal information
about Grantee, including, but not limited to, Grantee’s name, home address and telephone number,
date of birth, social insurance number or other identification number, salary, nationality, job
title, any shares of stock or directorships held in the Company, details of all Units or any
other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or
outstanding in Grantee’s favor, for the exclusive purpose of implementing, administering and
managing the Plan (“Data”).
	 
	 	 	Grantee understands that Data may be transferred to a stock plan service provider as may be
selected by the Company in the future, which would assist the Company with the implementation,
administration and management of the Plan. Grantee understands that the recipients of the Data
may be located in the United States or elsewhere, and that the recipients’ country (e.g., the
United States) may have different data privacy laws and protections than Grantee’s country.
Grantee understands that he or she may request a list with the names and addresses of any
potential recipients of the Data by contacting Grantee’s local human resources representative.
Grantee authorizes the Company and any other possible recipients which may assist the Company
(presently or in the future) with implementing, administering and managing the Plan to receive,
possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of
implementing, administering and managing Grantee’s participation in the Plan. Grantee
understands that Data will be held only as long as is necessary to implement, administer and
manage Grantee’s participation in the Plan. Grantee understands that Grantee may, at any time,
view Data, request additional information about the storage and processing of Data, require any
necessary amendments to Data or refuse or withdraw the consents herein, in any case without
cost, by contacting in writing Grantee’s local human resources representative. Grantee
understands, however, that refusing or withdrawing his or her consent may affect Grantee’s
ability to participate in the Plan. For more information on the consequences of Grantee’s
refusal to consent or withdrawal of consent, Grantee understands that Grantee may contact his or
her local human resources representative.
	 
	9.	 	Governing Law. The grant of Units and the provisions of this Agreement are governed by, and
subject to, the laws of the State of Delaware, without regard to the conflict of law
provisions, as provided in the Plan.
	 
	 	 	For purposes of litigating any dispute that arises under this grant or the Agreement, the
parties hereby submit to and consent to the jurisdiction of the State of Tennessee, agree that
such litigation shall be conducted in the courts of Shelby County, Tennessee, or the federal
courts for the United States for the Western District of Tennessee, where this grant is made
and/or to be performed.
	 
	10.	 	Language. If Grantee has received this Agreement or any other document related to the Plan
translated into a language other than English and if the meaning of the translated version is
different than the English version, the English version will control.

 

 

Phantom Stock Unit Grant Agreement

Page 8

	11.	 	Electronic Delivery. The Company may, in its sole discretion, decide to deliver any
documents related to current or future participation in the Plan by electronic means. Grantee
hereby consents to receive such documents by electronic delivery and agrees to participate in
the Plan through an on-line or electronic system established and maintained by the Company or
a third party designated by the Company.
	 
	12.	 	Severability. The provisions of this Agreement are severable and if any one or more
provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the
remaining provisions shall nevertheless be binding and enforceable.
	 
	13.	 	Appendix. Notwithstanding any provisions in this Agreement, the grant of Units shall be
subject to any special terms and conditions set forth in any Appendix to this Agreement for
Grantee’s country. Moreover, if Grantee relocates to one of the countries included in the
Appendix, the special terms and conditions for such country will apply to Grantee, to the
extent the Company determines that the application of such terms and conditions is necessary
or advisable in order to comply with local law or facilitate the administration of the Plan.
The Appendix constitutes part of this Agreement.
	 
	14.	 	Miscellaneous.

	 	14.1.	 	The Company reserves the right to impose other requirements on Grantee’s participation
in the Plan, on the Units and on any shares of Stock acquired under the Plan, to the extent
the Company determines it is necessary or advisable in order to comply with local law or
facilitate the administration of the Plan, and to require Grantee to sign any additional
agreements or undertakings that may be necessary to accomplish the foregoing.
	 
	 	14.2.	 	Any notice required or permitted hereunder shall be given in writing and shall be
deemed effectively given upon delivery to Grantee at the address of Grantee then on file
with the Company.
	 
	 	14.3.	 	This Agreement, subject to the provisions of the Appendix and Plan, constitutes the
entire agreement of the parties with respect to the subject matter hereof.

     This Agreement and the Units evidenced by this Agreement will not be effective until an
original signed Agreement is received by the Wright Medical Group, Inc. Legal Department. Please
print and sign this Agreement immediately, then send the signed Agreement to the Wright Medical
Group, Inc. Legal Department as soon as possible.

 

 

	 	 	 	 	 	 	 
	AGREED AND ACCEPTED:
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	GRANTEE:	 	WRIGHT MEDICAL GROUP, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 
	 	 
	 

	 	 	 	Jason P. Hood, Vice President,	 	 
	 

	 	 	 	General Counsel, and Secretary	 	 

 

 

APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

WRIGHT MEDICAL GROUP, INC.

PHANTOM STOCK UNIT GRANT AGREEMENT

(NON U.S. GRANTEES)

Terms and Conditions

This Appendix includes additional terms and conditions that govern the Units granted to Grantee
under the Plan if Grantee resides in one of the countries listed below. Certain capitalized terms
used but not defined in this Appendix have the meanings set forth in the Plan and/or the Agreement.

Notifications

This Appendix also includes information regarding exchange controls and certain other issues of
which Grantee should be aware with respect to Grantee’s participation in the Plan. The information
is based on the securities, exchange control and other laws in effect in the respective countries
as of September 2008. Such laws are often complex and change frequently. As a result, the Company
strongly recommends that Grantee not rely on the information in this Appendix as the only source of
information relating to the consequences of Grantee’s participation in the Plan because the
information may be out of date at the time that the Units vest or Grantee sells Stock acquired
under the Plan.

In addition, the information contained herein is general in nature and may not apply to Grantee’s
particular situation and the Company is not in a position to assure Grantee of a particular result.
Accordingly, Grantee is advised to seek appropriate professional advice as to how the relevant
laws in Grantee’s country may apply to Grantee’s situation.

Finally, if Grantee is a citizen or resident of a country other than the one in which Grantee is
currently working, the information contained herein may not be applicable to Grantee.

BELGIUM

There are no country specific provisions.

CANADA

Notifications

French Language Provision. The following provisions will apply if Grantee is a resident of Quebec:

The parties acknowledge that it is their express wish that this Agreement, as well as all
documents, notices and legal proceedings entered into, given or instituted pursuant hereto or
relating directly or indirectly hereto, be drawn up in English.

Les parties reconnaissent avoir exigé la redaction en anglais de cette convention
(“Agreement”), ainsi que de tous documents exécutés, avis donnés et procedures judiciaries
intentées, directement ou indirectement, relativement à la présente convention.

Termination of Service. This provision replaces Section 6(l) of the Agreement:

In the event of the termination of Grantee’s employment (whether or not in breach of local labor
laws), Grantee’s right to vest in Units under the Plan, if any, will terminate effective as of the
date that is the earlier of (1) the date Grantee receives notice of termination of Service from the
Company or the Employer, or (2) the date Grantee is no longer actively providing Service,
regardless of any notice period or period of pay in lieu of such notice required under local law
(including, but not limited to statutory law,

A-1

 

Phantom Stock Unit Grant Agreement

Page 2

regulatory law and/or common law); the Committee shall have the exclusive discretion to determine
when Grantee is no longer actively employed for purposes of the Units.

Data Privacy. This provision supplements paragraph 8 of the Agreement:

Grantee hereby authorizes the Company and the Company’s representatives to discuss with and obtain
all relevant information from all personnel, professional or not, involved in the administration
and operation of the Plan. Grantee further authorizes the Company, any Parent, Subsidiary or
Affiliate and the administrator of the Plan to disclose and discuss the Plan with their advisors.
Grantee further authorizes the Company and any Parent, Subsidiary or Affiliate to record such
information and to keep such information in Grantee’s employee file.

FRANCE

There are no country specific terms.

GERMANY

Notifications

Exchange Control Information. Cross-border payments in excess of €12,500 must be reported monthly
to the German Federal Bank. If Grantee uses a German bank to transfer a cross-border payment in
excess of €12,500 in connection with the sale of Stock acquired under the Plan, the bank will make
the report for Grantee. In addition, Grantee must report any receivables, payables, or debts in
foreign currency exceeding an amount of €5,000,000 on a monthly basis.

ITALY

Terms and Conditions

Data Privacy. This provision replaces in its entirety paragraph 8:

Grantee understands that the Employer and/or the Company may hold certain personal information
about Grantee, including, but not limited to, Grantee’s name, home address and telephone number,
date of birth, social security number (or any other social or national identification number),
salary, nationality, job title, number of Stock held and the details of all Units or any other
entitlement to Stock awarded, cancelled, exercised, vested, unvested or outstanding (the “Data”)
for the purpose of implementing, administering and managing Grantee’s participation in the Plan.
Grantee is aware that providing the Company with Grantee’s Data is necessary for the performance of
this Agreement and that Grantee’s refusal to provide such Data would make it impossible for the
Company to perform its contractual obligations and may affect Grantee’s ability to participate in
the Plan.

The Controller of personal data processing is [INSERT NAME AND CONTACT DETAILS OF ITALIAN
AFFILIATE]. Grantee understands that the Data may be transferred to the Company or any of its
Parent, Subsidiary or Affiliates, or to any third parties assisting in the implementation,
administration and management of the Plan, including any transfer required to a broker or other
third party with whom Stock acquired pursuant to the vesting of the Units or cash from the sale of
such Stock may be deposited. Furthermore, the recipients that may receive, possess, use, retain
and transfer such Data for the above mentioned purposes may be located in Italy or elsewhere,
including outside of the European Union and that the recipients’ country (e.g., the United States)
may have different data privacy laws and protections than Grantee’s country. The processing
activity, including the transfer of Grantee’s personal data abroad, outside of the European Union,
as herein specified and pursuant to applicable laws and regulations, does not require Grantee’s

A-2

 

Phantom Stock Unit Grant Agreement

Page 3

consent thereto as the processing is necessary for the performance of contractual obligations
related to the implementation, administration and management of the Plan. Grantee understands that
Data processing relating to the purposes above specified shall take place under automated or
non-automated conditions, anonymously when possible, that comply with the purposes for which Data
are collected and with confidentiality and security provisions as set forth by applicable laws and
regulations, with specific reference to D.lgs. 196/2003.

Grantee understands that Data will be held only as long as is required by law or as necessary to
implement, administer and manage Grantee’s participation in the Plan. Grantee understands that
pursuant to art.7 of D.lgs 196/2003, Grantee has the right, including but not limited to, access,
delete, update, request the rectification of Grantee’s Data and cease, for legitimate reasons, the
Data processing. Furthermore, Grantee is aware that Grantee’s Data will not be used for direct
marketing purposes. In addition, the Data provided can be reviewed and questions or complaints can
be addressed by contacting a local representative available at the following address: [INSERT].

Plan Document Acknowledgment. In accepting the Units, Grantee acknowledges that Grantee has
received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement,
including this Appendix, in their entirety and fully understands and accepts all provisions of the
Plan and the Agreement, including this Appendix. Grantee further acknowledges that Grantee has
read and specifically and expressly approves the following paragraphs of the Agreements: Vesting
Schedule, Conversion into Stock, Responsibility for Taxes, Nature of Grant and Data Privacy.

Notifications

Exchange Control Information. Grantee is required to report in Grantee’s annual tax return: (a)
any transfers of cash or Stock to or from Italy exceeding €10,000 or the equivalent amount in U.S.
dollars; and (b) any foreign investments or investments (including proceeds from the sale of Units
acquired under the Plan) held outside of Italy exceeding €10,000 or the equivalent amount in U.S.
dollars, if the investment may give rise to income in Italy. Grantee is exempt from the
formalities in (a) if the investments are made through an authorized broker resident in Italy, as
the broker will comply with the reporting obligation on Grantee’s behalf.

JAPAN

There are no country specific provisions.

NETHERLANDS

Notifications

Insider-Trading Notification. Grantee should be aware of the Dutch insider-trading rules, which
may impact the sale of Stock issued to Grantee at vesting and settlement of the Units. In
particular, Grantee may be prohibited from effectuating certain transactions involving Stock if
Grantee has inside information about the Company. If Grantee is uncertain whether the
insider-trading rules apply to Grantee, Grantee should consult Grantee’s personal legal advisor.

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following provisions supplement paragraph 5 of the Agreement:

A-3

 

Phantom Stock Unit Grant Agreement

Page 4

Grantee agrees that if Grantee does not pay or the Employer or the Company does not withhold from
Grantee the full amount of Tax-Related Items that Grantee owes due to the vesting of the Units, or
the release or assignment of the Units for consideration, or the receipt of any other benefit in
connection with the Units (the “Taxable Event”) within 90 days after the Taxable Event, or such
other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act
2003, then the amount that should have been withheld shall constitute a loan owed by Grantee to the
Employer, effective 90 days after the Taxable Event. Grantee agrees that the loan will bear
interest at the HM Revenue and Custom’s official rate and will be immediately due and repayable by
Grantee, and the Company and/or the Employer may recover it at any time thereafter by withholding
the funds from salary, bonus or any other funds due to Grantee by the Employer, by withholding in
Stock issued upon vesting and settlement of the Units or from the cash proceeds from the sale of
Stock or by demanding cash or a cheque from Grantee. Grantee also authorizes the Company to delay
the issuance of any Stock to Grantee unless and until the loan is repaid in full.

Notwithstanding the foregoing, if Grantee is an officer or executive director (as within the
meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), the terms of
the immediately foregoing provision will not apply. In the event that Grantee is an officer or
executive director and Tax-Related Items are not collected from or paid by Grantee within 90 days
of the Taxable Event, the amount of any uncollected Tax-Related Items may constitute a benefit to
Grantee on which additional income tax and national insurance contributions may be payable.
Grantee acknowledges that the Company or the Employer may recover any such additional income tax
and national insurance contributions at any time thereafter by any of the means referred to in
paragraph 5 of the Agreement.

A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]